{
    "title": "109_hr1822",
    "content": "The \"Human Cloning Ban and Stem Cell Research Protection Act of 2005\" prohibits human cloning and aims to protect important medical research areas, including stem cell research. The Act adds a new chapter to the Federal Food, Drug, and Cosmetic Act, specifically prohibiting human cloning. The \"Human Cloning Ban and Stem Cell Research Protection Act of 2005\" defines key terms related to human cloning, such as human cloning, human somatic cell, nuclear transplantation, nucleus, oocyte, and unfertilized blastocyst. The \"Human Cloning Ban and Stem Cell Research Protection Act of 2005\" prohibits human cloning, shipping nuclear transplantation products for cloning purposes, and exporting unfertilized blastocysts to countries that allow cloning. The \"Human Cloning Ban and Stem Cell Research Protection Act of 2005\" prohibits human cloning and imposes criminal penalties for violations, including imprisonment for up to 10 years and fines. The act also clarifies that it does not restrict practices not expressly prohibited and does not provide individuals with a private right of action. The \"Human Cloning Ban and Stem Cell Research Protection Act of 2005\" imposes civil penalties for violations, with fines up to $10,000,000 or three times the gross pecuniary gain. It also includes provisions for forfeiture of assets related to the violation. The Cosmetic Act has been amended to include forfeiture of property related to violations of section 301(hh) to the United States. SEC. 102. Oversight reports on actions to enforce certain prohibitions. The Secretary of HHS must submit a report to the Senate and House committees within a year of the enactment of the Act, detailing enforcement actions on human cloning and violations of the Federal Food, Drug, and Cosmetic Act. Additionally, a report on coordinating enforcement actions among federal, state, and local governments regarding human cloning must be submitted within the same timeframe. The Secretary of HHS is required to submit a report to Senate and House committees within a year of the Act's enactment, detailing enforcement actions on human cloning and violations of the Federal Food, Drug, and Cosmetic Act. The report should also cover coordination of enforcement actions among federal, state, and local governments regarding human cloning. (c) Report on International Laws Relating to Human Cloning.--Within a year of the Act's enactment, the Secretary of Health and Human Services must submit a report on international laws concerning human cloning to relevant committees. The Secretary of Health and Human Services is required to submit a report to Congress detailing foreign laws on human cloning, enforcement actions by foreign countries, and international efforts to ban human cloning. Title II of the Public Health Service Act is amended to include ethical requirements for nuclear transplantation research, covering informed consent, institutional review board review, and safety and privacy protection. The definitions for terms like donating, fertilization, and valuable consideration are outlined in this section, with valuable consideration excluding certain payments related to oocyte transportation and research. Research involving nuclear transplantation must adhere to federal ethical standards outlined in specific regulations. Somatic cell nucleus transplant into a fertilized human oocyte is prohibited, and an unfertilized blastocyst cannot be maintained for more than 14 days. In nuclear transplantation research, oocytes must be voluntarily donated with informed consent. Acquisition or transfer of oocytes for valuable consideration is prohibited. Nuclear transplantation and in vitro fertilization labs must be separate. In nuclear transplantation research, oocytes must be voluntarily donated with informed consent and cannot be acquired or transferred for valuable consideration. Labs conducting transplantation cannot be the same as those performing assisted reproductive technology treatments. Violators of these regulations may face civil penalties up to $250,000."
}